Oncodesign Company

Oncodesign develops anticancer therapies for the treatment of patients with cancer.

Headquarters: Others
Industry: P4 Medicine
Employee Number: 101-250
Estimated Revenue: $1M to $10M
Investors Number: 3
Investor Type: For Profit
Funding Status: IPO
Technology: Precision Medicine
Last Funding Type: Venture - Series Unknown
Founded Date: 1995-01-01
Total Funding: $29.4M